Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Liquent is a leading provider of regulatory information management (RIM) software and services tailored for the life sciences industry. The company's flagship platform, Liquent InSight, enables pharmaceutical, biotechnology, and medical device companies to manage the entire regulatory lifecycle, from planning and authoring to the electronic submission (eCTD) of drug applications. By combining advanced technology with professional consultancy, Liquent helps organizations navigate complex global compliance requirements and accelerate time-to-market for new therapies. Following its acquisition by PAREXEL in 2012, Liquent's capabilities were integrated into PAREXEL's regulatory consulting and informatics business. The company was a pioneer in the transition from paper-based to electronic regulatory filings, setting industry standards for submission management.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Liquent.